Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
3315.HK Stock Summary
In the News
3315.HK Financial details
Company Rating
Buy
Market Cap
1.15B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.04
Dividend %
2.82%
Employees
1.51K
Optionable
No
Shortable
Yes
Earnings
22 Aug 2023
P/E
7.2
Forward P/E
-
PEG
-
P/S
0.69
P/B
0.52
P/C
-
P/FCF
-33.18
Quick Ratio
1.41
Current Ratio
2.57
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
5.88%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.04%
Revenue last 5Y
1.63%
Revenue Q/Q
3.19%
EPS Q/Q
-
-
-
-
-
SMA20
1.45%
SMA50
-
SMA100
-7.28%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
7%
ROC
0.08%
Gross Margin
26%
Oper. Margin
11%
Profit Margin
10%
Payout
66%
Shs Outstand
811.43M
Shs Float
508.66M
-
-
-
-
Target Price
-
52W Range
1.32-1.76
52W High
+40%
52W Low
+40%
RSI
49.56
Rel Volume
0.84
Avg Volume
118.42K
Volume
100K
Perf Week
-0.71%
Perf Month
0.72%
Perf Quarter
-7.28%
Perf Half Y
-6.67%
-
-
-
-
Beta
0.5
-
-
Volatility
0.03%, 0.03%
Prev Close
-2.1%
Price
1.4
Change
-2.1%
3315.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.71 | 1.71 | 1.55 | 1.67 | 1.88 | |
Net income per share | 0.21 | 0.21 | 0.18 | 0.17 | 0.18 | |
Operating cash flow per share | 0.11 | 0.3 | 0.24 | -0.01 | 0.04 | |
Free cash flow per share | 0.06 | 0.19 | 0.14 | -0.1 | -0.04 | |
Cash per share | 1.58 | 1.64 | 1.64 | 1.33 | 1.22 | |
Book value per share | 2.39 | 2.42 | 2.42 | 2.44 | 2.52 | |
Tangible book value per share | 2.36 | 2.42 | 2.41 | 2.44 | 2.54 | |
Share holders equity per share | 2.39 | 2.42 | 2.42 | 2.44 | 2.52 | |
Interest debt per share | 0 | 0.02 | 0.02 | 0.02 | 0.08 | |
Market cap | 1.37B | 1.33B | 992.54M | 1.12B | 1.14B | |
Enterprise value | 1.05B | 1.12B | 632.47M | 819.87M | 562.22M | |
P/E ratio | 7.84 | 7.49 | 6.81 | 8.12 | 7.71 | |
Price to sales ratio | 0.97 | 0.94 | 0.77 | 0.82 | 0.74 | |
POCF ratio | 15.29 | 5.29 | 5.03 | -236.27 | 32.35 | |
PFCF ratio | 29.38 | 8.48 | 8.48 | -12.98 | -35.68 | |
P/B Ratio | 0.69 | 0.66 | 0.5 | 0.56 | 0.55 | |
PTB ratio | 0.69 | 0.66 | 0.5 | 0.56 | 0.55 | |
EV to sales | 0.75 | 0.79 | 0.49 | 0.6 | 0.37 | |
Enterprise value over EBITDA | 3.97 | 4.31 | 2.95 | 4.24 | 2.62 | |
EV to operating cash flow | 11.72 | 4.48 | 3.2 | -172.6 | 16.01 | |
EV to free cash flow | 22.52 | 7.18 | 5.4 | -9.49 | -17.66 | |
Earnings yield | 0.13 | 0.13 | 0.15 | 0.12 | 0.13 | |
Free cash flow yield | 0.03 | 0.12 | 0.12 | -0.08 | -0.03 | |
Debt to equity | 0 | 0.01 | 0.01 | 0.01 | 0.03 | |
Debt to assets | 0 | 0.01 | 0.01 | 0.01 | 0.02 | |
Net debt to EBITDA | -1.21 | -0.78 | -1.68 | -1.57 | -2.67 | |
Current ratio | 3.22 | 3.22 | 3.7 | 3.15 | 2.57 | |
Interest coverage | 0 | 234.53 | 300.8 | 192.82 | 20.17 | |
Income quality | 0.43 | 1.21 | 1.17 | -0.03 | 0.21 | |
Dividend Yield | 0.1 | 0.11 | 0.14 | 0.1 | 0.09 | |
Payout ratio | 0.8 | 0.83 | 0.98 | 0.81 | 0.66 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Research and developement to revenue | 0.08 | 0.08 | 0.09 | 0.09 | 0.07 | |
Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0.09 | |
Capex to operating cash flow | -0.48 | -0.38 | -0.41 | 17.2 | -1.91 | |
Capex to revenue | -0.03 | -0.07 | -0.06 | -0.06 | -0.04 | |
Capex to depreciation | -0.93 | -1.76 | -1.64 | -1.93 | -1.54 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Graham number | 3.38 | 3.42 | 3.1 | 3.03 | 3.21 | |
ROIC | 0.08 | 0.09 | 0.07 | 0.07 | 0.08 | |
Return on tangible assets | 0.07 | 0.07 | 0.06 | 0.05 | 0.06 | |
Graham Net | 0.92 | 0.98 | 1.06 | 0.77 | 0.53 | |
Working capital | 1.38B | 1.33B | 1.47B | 1.22B | 1.11B | |
Tangible asset value | 1.95B | 2B | 1.99B | 2.01B | 1.83B | |
Net current asset value | 1.35B | 1.29B | 1.44B | 1.18B | 1.08B | |
Invested capital | 0 | 0.01 | 0.01 | 0.01 | 0.03 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 410.17M | 275.98M | 323.88M | 393.97M | 379.6M | |
Average inventory | 209.78M | 198.31M | 187.53M | 238.65M | 324.77M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 96.39 | 101.32 | 148.52 | 158.59 | 109.03 | |
Days of inventory on hand | 75.77 | 66.27 | 77.37 | 107.7 | 117.43 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 3.79 | 3.6 | 2.46 | 2.3 | 3.35 | |
Inventory turnover | 4.82 | 5.51 | 4.72 | 3.39 | 3.11 | |
ROE | 0.09 | 0.09 | 0.07 | 0.07 | 0.07 | |
Capex per share | -0.05 | -0.11 | -0.1 | -0.1 | -0.08 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | -345.06M | -302.42M | -115.96M | -573.9M | -356.18M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.01 | 0.01 | 0.08 | 0.03 | 0 | |
Debt to assets | 0.01 | 0.01 | 0.06 | 0.02 | 0 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 3.32 | 3.15 | 2.4 | 2.57 | 2.98 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0.09 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 1.23B | 1.22B | 1.08B | 1.11B | 1.39B | |
Tangible asset value | 1.97B | 2.01B | 1.99B | 1.83B | 2.04B | |
Net current asset value | 1.2B | 1.18B | 1.05B | 1.08B | 1.35B | |
Invested capital | 0.01 | 0.01 | 0.08 | 0.03 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 377.1M | 405.64M | 439.44M | 396.53M | 399.73M | |
Average inventory | 205.77M | 254.04M | 317.53M | 355.38M | 363.45M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
3315.HK Frequently Asked Questions
What is Goldpac Group Limited stock symbol ?
Goldpac Group Limited is a HK stock and trading under the symbol 3315.HK
What is Goldpac Group Limited stock quote today ?
Goldpac Group Limited stock price is $1.4 today.
Is Goldpac Group Limited stock public?
Yes, Goldpac Group Limited is a publicly traded company.